Invitation to comment on a field trial of genetically modified perennial ryegrass

The Gene Technology Regulator is assessing an application from Grasslanz Technology Australia Pty Limited to conduct a field trial of perennial ryegrass genetically modified for increased metabolisable energy content. The trial is proposed to run from April 2023 to December 2028 at up to 7 sites per year, with a maximum total area of 12.5 ha over the 5-year trial period. Sites would be selected from 119 local government areas in NSW, Vic, Qld, and WA. The GM perennial ryegrass grown in this field trial would not be used for human food or commercial animal feed.

The Regulator has prepared a Risk Assessment and Risk Management Plan (RARMP) for this application and welcomes written submissions relating to the protection of human health and safety and the environment prior to making a decision on whether to issue the licence. The consultation RARMP and related information can be obtained via our website (search for DIR 194), or from the contacts below. Submissions should reference DIR 194 and be received by 17 January 2023.

Office of the Gene Technology Regulator
MDP 54 GPO Box 9848 CANBERRA ACT 2601

Telephone: 1800 181 030 Website: www.ogtr.gov.au

E-mail: ogtr@health.gov.au